Next, we reclustered the 1,184 Trm-like cells from B-ALL patients and healthy individuals into two subtypes, CD4+ and CD8+ Trm-like cells, according to the expression of CD4 and CD8A (Figures 2C, D). This evidence concerns the gene CD4 and precursor B-cell acute lymphoblastic leukemia.